U.S. Sen. Susan Collins, R-Maine, has called for several legislative steps intended to increase drug price competition, including giving priority review to drugmakers that develop cheaper versions of drugs that are only available from a single company.

Augusta and Waterville news

Get news and events from your towns in your inbox every Friday.


  • This field is for validation purposes and should be left unchanged.